SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
FDA Recall #D-0388-2026 — Class I — October 20, 2025
Product Description
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Reason for Recall
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Recalling Firm
ANTHONY TRINH, 123Herbals LLC — Rosemead, CA
Classification
Class I — Reasonable probability of serious adverse health consequences or death.
Product Type
Drugs
Product Quantity
N/A
Distribution
USA nationwide
Code Information
All lots within expiry
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated